Seasonal Allergy

Food Allergy

Anaphylaxis

Allergy

Biosimilars

Dyslipidemia

Arrhythmia

Structural Heart Disease

Atherosclerotic Cardiovascular Disease

Heart Failure

Lipid Management

Hypertension

Stroke

Venous Thromboembolism

Cardiology

Vitiligo

Acne

Atopic Dermatitis

Chronic Idiopathic Urticaria

Plaque Psoriasis

Rosacea

Dermatology

Type 2 Diabetes

Type 1 Diabetes

Polycystic Ovary Syndrome

Hormonal Disorders

Thyroid Disorders

Endocrinology

FDA News

COVID-19

Influenza

Vaccination

Family Medicine

C Difficile Infection

Gastroesophageal Reflux Disease (GERD)

Hepatitis C

Irritable Bowel Syndrome

Peptic Ulcer

Ulcerative Colitis

Gastroenterology

Alzheimer Disease

Parkinson Disease

Geriatrics

Hepatology

Hospital Medicine

HIV/AIDS

Infectious Disease

Internal Medicine

Chronic Kidney Disease

Nephrology

Epilepsy

Migraine

Tardive Dyskinesia

Traumatic Brain Injury

Neurology

Obesity Management

Geographic Atrophy

Age-Related Macular Degeneration

Diabetic Macular Edema

Uveitis

Ophthalmology

Acute Pain

Chronic Pain

Multiple Sclerosis

Neuropathic Pain

Pain

Pediatrics

PTSD

Addiction

ADHD

Bipolar Disorder

Major Depressive Disorder

Schizophrenia

Psychiatry

Lung Cancer

Pulmonary Fibrosis

Asthma

COPD

Pulmonology

Vasculitis

Sickle Cell

Amyloidosis

Huntington Disease

Lysosomal Storage Disorders

Rare Disease Report®

Lupus

Osteoporosis

Non-radiographic Axial Spondyloarthritis

Ankylosing Spondylitis

Fibromyalgia

Gout

Osteoarthritis

Psoriatic Arthritis

Rheumatoid Arthritis

Spondyloarthritis

Rheumatology

Obstructive Sleep Apnea

Insomnia

Sleep

Plastic surgery

Surgery

Women's Health

News

Media

Medical World News

Podcasts

Shows

State Of Sciences - Presentations

Videos

Webinars

Multimedia Series

CURE Connections®

Insights

Medcast Podcasts

Medcast Videos

Peer Exchange

Peers & Perspectives

Conferences

Conference Coverage

Conference Listing

Partners

CME/CE

Resources

Interactive Tools

Live Events

Press Release

Publications

Subscribe

. Prior to joining MJH Life Sciences in 2019, he worked as a digital reporter covering nanotechnology, life sciences, material science and more with 

. He graduated with a degree in journalism from Temple University in 2008 and began his career as a local reporter for a chain of weekly newspapers based on the Jersey shore. When not working, he enjoys going to the beach and enjoying the shore in the summer and watching North Carolina Tar Heel basketball in the winter.

Articles

The threshold values for the SOF/VEL prophylaxis strategies showed that the 4-week strategy likely won’t be less costly under any reasonable value of the input variables.

Short Duration DAA Prophylaxis Could Be Cost Beneficial Option for HCV Donor Transplantations

Tim Smith joined the MJH Life Sciences team as an assistant editor for HCPLive in August 2022. He graduated from UC Berkeley with a degree in political science, working in multimedia journalism as a staff writer prior to joining MJH. In his spare time, he enjoys reading, watching TV, listening to podcasts, and rock climbing. You can contact him at 

New data on oral immunotherapy to food allergens shows promise for the treatment, though more information with standard interventions and regimens is needed to gain certainty on the efficacy and safety.


Oral Immunotherapy Shown to Be Effective in Desensitization for Egg, Milk, Peanut Allergy

There were higher percentages of patients treated with mirikizumab that had clinical remission at week 12 of the induction trial compared to the placebo group. This was also true at week 40 of the maintenance trial.

Mirikizumab Bests Placebo in Treating Patients With Ulcerative Colitis 

New late-breaking phase 3 data showed success with nemolizumab, an investigational drug designed for targeting IL-31 signaling and aimed at the underlying causes of the condition.


Nemolizumab Monotherapy Successful in Prurigo Nodularis Patients Becoming Itch-Free

HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care to patients. At HCPLive, you will find breaking news, video interviews with physician experts, in-depth conference coverage, finance and practice management updates, insight and analysis from physician contributors, and more.

About Us

Advertise

Editorial

Contact Us

Do Not Sell My Information

Privacy

Terms & Conditions

HCPLive - Clinical news for connected physicians

Facebook

Twitter

LinkedIn

Spotlight

Biosimilars Spotlight

Qazi Corner

This Year In Medicine 2022

Clinical

Arterial Disease

Diabetes

Geriatric Medicine

Video Series

News Network

Post Conference Perspectives

Register today to join our colleagues at OncLive

 for an exclusive event on December 8, 2022. You and your peers have the 

option of joining us live, in-person at 7 locations across the US

 or virtaully from the comfort of your home or office. Discover new insights on 

 (HCC) designed to improved patient outcomes.

Discuss current frontline treatment options and unmet needs for patients with advanced HCC

Share expert insight on recent updates to the HCC treatment armamentarium

Analyze new data and therapies on the horizon for unresectable HCC

7:00pm ET | 6:00pm CT | 5:00pm MT | 4:00pm PT

9:00pm ET | 8:00pm CT | 7:00pm MT | 6:00pm PT

Gaining Ground: New Options for Advanced HCC

HCPLive® State of the Science events are short meetings designed to educate health care providers on the clinical benefits associated with the new science driving new thinking in their field. Our renowned faculty focus on the most relevant topics so HCP attendees improve their knowledge of treatment approaches and leave our events with the confidence and intent to apply these lessons learned to improve patient care.

Registration for this virtual event is complimentary and HCPs are encouraged to share their feedback in our post-event survey.



State of Science Summit in Psychiatry: Addressing Challenges in Depression Treatment

The Role of JAK Inhibition in Vitiligo Treatment

State of the Science Summit in Dermatology: Vitiligo

HCPLive® State of the Science events are short meetings designed to educate health care providers on the clinical benefits associated with the new science driving new thinking in their field. Our renowned faculty focus on the most relevant topics so HCP attendees improve their knowledge of treatment approaches and leave our events with the confidence and intent to apply these lessons learned to improve patient care.

Registration for this virtual event is complimentary and HCPs are encouraged to share their feedback in our post-event survey.

Psychedelic Medicine and the Future of Psychiatry

Psychedelic-Assisted Psychotherapy for Depression

State of the Science in Psychiatry: Addressing Challenges in Depression Treatment

Join Linda Stein Gold, MD and Larry Eichenfield, MD for an informative presentation about recent developments in atopic dermatitis (AD). They will review the evolving understanding of AD, diagnosis, management, the patient journey, and new novel treatment option in a presentation hosted by Incyte Dermatology.

The Burden of Atopic Dermatitis and a Novel Topical Pathway

, chief medical officer with the American Lung Association and clinical assistant professor of medicine at Sidney Kimmel Medical College, for a live webinar event on 

along with an esteemed panel of experts to hear how the COVID-19 pandemic affected lung cancer screening and treatment.

Opportunities borne from effective screening

Effective screening-to-treatment plans: what does it look like for a patient?

Part 2 - Lung Cancer Screening & Treatment: What Comes Next?

Topics of discussion include:
•Recent research and trends into lung cancer screening
•The clinical impact of lacking screening
•The effect of COVID-19 on lung cancer screening
•The US Preventive Services Task Force 2021 Lung Cancer Screening Guidelines

Lung Cancer Screening & Treatment After COVID-19

State of Sciences-Presentations

1rem

Thought leaders examine challenges and opportunities in HCV screening and prevention, in highlights from a recent State of the Science SummitTM, presented by HCP Live®

Updates on HCV Screening, Access to Treatment, and Prevention

Experts share treatment insights on the management of patients with treatment resistant depression, in highlights from a recent State of the Science SummitTM, presented by HCP Live®.

Treatment Resistant Depression: Clinical and Practical Considerations

Experts share insights on evolving knowledge and treatment approaches regarding vitiligo, in highlights from a recent State of the Science SummitTM, presented by HCP Live®.

Vitiligo: Practical Considerations for a Changing Therapeutic Landscape